Articles tagged with Osteoporosis
A new review emphasizes the importance of both physical activity and reduced sedentary time for optimal skeletal health. Emerging evidence reveals that prolonged sitting and inactivity can harm bone health, even among regular exercisers.
A comprehensive study of Singaporean women in their 20s-30s found that nearly one in four healthy-weight Chinese women already have low muscle mass and weaker bones, despite appearing healthiest by BMI standards. The study highlights the need for healthcare approaches that consider body composition beyond simple weight measurements.
A recent study published in the Journal of the Endocrine Society found that skipping breakfast and having late dinners are associated with an increased risk of osteoporosis. Additionally, unhealthy eating habits were linked to other lifestyle risk factors such as physical inactivity, smoking, and insufficient sleep.
Researchers explore the benefits of nucleic acid aptamers in targeted therapies for bone tissue regeneration, revealing their potential in managing orthopedic conditions. Aptamers can modulate key molecular pathways involved in bone repair, advancing the standard of care for fractures and various types of bone diseases.
The International Osteoporosis Foundation has issued an updated joint position statement on managing aromatase inhibitor-associated bone loss in women with hormone-sensitive breast cancer. The guidelines incorporate recent clinical trials and systematic reviews to provide evidence-based treatment algorithms for assessing fracture risk ...
Scientists at Leipzig University have discovered that the adhesion G protein-coupled receptor GPR133 plays a central role in building and maintaining healthy bone. By mimicking natural activation, a new active substance AP503 can strengthen bones and potentially treat osteoporosis.
A study published by The Endocrine Society found that obesity and early type 2 diabetes in adolescence can interfere with bone development, potentially increasing the risk of fractures and osteoporosis later in life. Researchers followed 48 teenagers for a year, finding that teens with obesity and type 2 diabetes showed less improvemen...
A recent study published by The Endocrine Society found that osteoporosis treatment after a fracture can decrease both hospitalization and mortality in people older than 80. Researchers analyzed data from 88,676 patients aged 80 and older who suffered a fracture due to bone deterioration or weakness caused by osteoporosis.
Researchers have developed an AI-assisted diagnostic system that can estimate bone mineral density in the lumbar spine and femur with high sensitivity and specificity. The system has the potential to transform routine clinical X-rays into a powerful tool for opportunistic screening, enabling earlier detection of osteoporosis.
A new survey conducted by Ohio State University Wexner Medical Center found that only 1% of men are concerned about bone density, with cancer and heart disease being top concerns. Men can build back bone density through exercise, nutrition, and lifestyle changes, and early intervention can prevent deadly fractures.
A team of researchers from the University of São Paulo identified agrin as a crucial protein in maintaining bone mass and quality. The study found that osteocytes produce agrin, which plays an essential role in preserving bone health. Without agrin, bone tissue becomes less dense and more fragile, making bones susceptible to fractures.
A new study found that weighted vests and resistance training did not prevent bone loss in older adults undergoing intentional weight loss. The researchers call for alternative strategies to protect skeletal health in aging populations with obesity.
A comprehensive review highlights the impact of anti-cancer treatments on bone health, increasing the risk of fractures and bone fragility. The International Osteoporosis Foundation advocates for a multidisciplinary approach to early screening and proactive bone-protective strategies.
A landmark review highlights how diabetes alters bone microarchitecture and increases fracture risk in people with type 2 diabetes, despite normal or elevated bone mineral density. The authors advocate for updated diagnostic tools, including a revised TBS algorithm, to more accurately reflect bone quality in individuals with central ob...
Scientists have discovered NELL2's dual role in boosting bone formation and inhibiting fat accumulation in osteoporosis, promoting osteoblast differentiation and suppressing adipocyte formation. The study reveals NELL2's activation of the FAK/AKT signaling pathway through interactions with Fibronectin 1 and integrins.
The IOF Advanced Course on Osteoporosis is a comprehensive, 18-hour online training programme designed to equip healthcare professionals with the latest knowledge in osteoporosis prevention, diagnosis, and management. The course aims to promote timely diagnosis and treatment, reduce patient burden, and improve global outcomes.
The European Society of Endocrinology and the European Hormone and Metabolism Foundation launch a global campaign to raise awareness about hormone balance and its impact on chronic diseases. Small steps can make a big difference in improving hormone health.
Twelve young researchers from around the world receive ESCEO-IOF Young Investigator Awards for their groundbreaking studies on osteoporosis. The prestigious awards were presented during the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2025) in Rome, Italy.
Dr. Elizabeth M. Curtis has been awarded the ESCEO-IOF Pierre Meunier Young Scientist Award for her groundbreaking research on musculoskeletal health and bone disease. Her work focuses on the epidemiology of bone, muscle health, and joint health across the lifespan.
Dr Ambrish Mithal, an Indian endocrinologist, has been awarded the prestigious IOF CSA Medal of Achievement for his groundbreaking work in advancing the field of osteoporosis. His pioneering efforts have significantly increased understanding and awareness of osteoporosis globally.
AMMOM has been recognized by the IOF for its significant contributions to osteoporosis awareness and bone health in Mexico. The organization has collaborated extensively with the IOF on various initiatives, including joint scientific meetings and advocacy efforts.
Professor Atsushi Suzuki, Chair of Endocrinology at Fujita Health University School of Medicine, Japan, received the IOF President's Award for his exceptional contributions to IOF. He has shared his expertise as a mentor and engaged member of the Capture the Fracture Governance.
A new consensus paper emphasizes the role of bone turnover markers (BTMs) in diagnosing and managing osteoporosis. BTMs, such as procollagen type I N propeptide (PINP) and β-isomerized C-terminal telopeptide of type I collagen (β-CTX-I), are invaluable tools for predicting fracture risk and monitoring treatment adherence.
A recent study found that everyday physical activity does not slow bone loss during menopause, contrary to previous studies suggesting exercise can mitigate age-related bone weakening. Despite this, researchers believe more targeted exercise may help slow hormonal bone loss.
A recent study by Hong Xue analyzed over 15 years of data to identify trends in osteoporosis prevalence and diagnosis. Non-Hispanic White women had the highest prevalence of diagnosed osteoporosis, while nearly 70% of individuals with osteoporosis remained undiagnosed.
A USC study found proteins and pathways involved in inflammation are associated with changes in bone mineral density (BMD) over time. The research identified potential biomarkers that could serve as early indicators of a person's risk for bone health issues later in life.
A rare case report highlights the association between systemic mastocytosis and severe osteoporosis in a young adult patient, emphasizing the importance of early diagnosis and consideration of SM as an underlying cause. The study aims to raise awareness about this underrecognized condition and its potential impact on bone health.
Researchers found that bimagrumab increases bone tissue while building muscle mass, reducing the risk of osteoporosis. The study suggests bimagrumab could be part of a second-generation weight loss drug on the market.
Researchers have developed an injectable hydrogel that targets rapid localized increase in bone density. The results show a four- to five-fold increase in bone density in the legs of rats with bone loss. The study combines systemic osteoporosis drugs with local hydrogel injections, offering hope for future fracture prevention therapies.
A new pilot study sheds light on the numerous barriers to effective osteoporosis management, revealing profound knowledge gaps and misinformation. Key findings highlight the need for clear education and trust-building in osteoporosis care.
Researchers identify Fam102a as a key regulator of both osteoclast and osteoblast differentiation, leading to enhanced osteoblast formation and bone volume. The study reveals significant protein-protein interactions involving Fam102a and Kpna2, shedding light on the critical molecular interactions involved in bone remodeling.
Researchers have identified molecular mechanisms by which osteoporosis medications protect against Covid-19. The study suggests that compounds like alendronate and zoledronate may be beneficial in preventing SARS-CoV-2 infection and related hospitalizations.
The USPSTF concludes that screening for osteoporosis can help prevent fractures in older women. However, the effectiveness of screening for men is unclear due to insufficient evidence.
A new position paper from the International Osteoporosis Foundation and International Federation of Clinical Chemistry proposes a unified nomenclature for bone status indices to enhance diagnostic consistency and clarity. The guidelines offer a comprehensive framework to unify terminology and improve comparability across studies.
The article highlights the critical role of Fracture Liaison Services (FLS) in combating rising osteoporosis-related fractures. FLS programs have been shown to reduce secondary fracture risk by up to 74% and deliver a return of $10.49 for every $1 invested.
Researchers discover that osteogenic CpG oligodeoxynucleotide iSN40 inhibits osteoclast differentiation and reduces bone resorption. This balanced approach could provide a new treatment option for osteoporosis, an imbalance in bone remodeling characterized by excessive bone resorption.
Researchers used AI on CT scans originally meant for tumors to detect calcium buildup in arteries, a sign of worsening cardiovascular disease. The study found that this opportunistic screening could predict heart attacks or other cardiovascular events with high accuracy.
This special issue of Calcified Tissue International presents a collection of critical reviews and original research articles on osteogenesis imperfecta (OI), covering essential aspects of the condition, including its nosology, genetics, and clinical presentation. The contributions also discuss treatment strategies for both children an...
Researchers have identified two genes, ATXN2L and MMP14, linked to both rheumatoid arthritis and osteoporosis. These genes play a role in apoptosis, immune regulation, and bone metabolism.
The International Osteoporosis Foundation's Capture the Fracture campaign highlights top-performing Fracture Liaison Services that deliver gold-standard care. These services prioritize continuous care, tailored treatment plans, and teamwork to reduce secondary fractures and improve patient outcomes.
A new study found that people with severe mental illness are more likely to experience fragility fractures than the general population. The researchers analyzed GP records of over 440,000 people between 2000 and 2018 and found a significant association between severe mental illness and fragility fractures.
A team of researchers discovered a protein that blocks bone-forming cells by preventing them from maturing. The study found that the protein CLEC14A reduces bone formation, while its absence leads to increased mineralized bone tissue.
A new study led by Penn State researchers found that high-level collegiate sports stress can lead to unhealthy attitudes about eating and inadequate caloric intake. Athletes, especially female ones, are at risk for energy deficiency, eating disorders, and bone loss if they don't consume enough calories.
Research at the University of Tsukuba found high vertebral instability and diffuse low-signal changes in T2-weighted MRI observations to be risk factors for deteriorated ambulation status following different conservative treatments. These findings could help predict whether a patient's ability to walk will be affected by these treatments.
A new study found that bone fracture rates in older women differ dramatically by race, with White women having the highest risk. Hispanic women had a lower risk of 10%, while Asian-American women experienced varying fracture rates depending on their ethnicity. The study highlights the need to better understand factors behind these diff...
Researchers found that osteoporosis is independently associated with rapid leukocyte telomere length shortening over a 2-year period. A total of 233 subjects were enrolled in the study, and multivariable linear regression analysis indicated that only osteoporosis was significantly linked to LTL shortening.
A new position paper argues that single race-agnostic FRAX models would unfairly discriminate against Black, Asian, and Hispanic communities. The authors recommend retention of ethnic and race-specific FRAX models for the US with updated data on fracture and death hazards.
Scientists have discovered a new hormone, CCN3, that helps maintain bone density and strength in breastfeeding women. In mice, CCN3 increased bone mass and strength, even when estrogen levels were low. The hormone also accelerated bone healing in fracture models, offering hope for treating osteoporosis and other bone conditions.
Researchers linked impaired blood vessel function with lower bone density and worse bone microstructure, but found no independent causal pathway. The study suggests shared risk factors may be more important in the development of osteoporosis than vascular dysfunction.
A research team from Osaka University identified a key osteoporosis-related gene, Men1, and developed a new animal model of the disease. The study found that inactivation of Men1 led to cellular senescence in osteoblasts, reducing bone formation activity and increasing bone resorption.
A newly developed deep learning algorithm has outperformed existing methods in predicting osteoporosis risk, potentially leading to earlier diagnoses and better outcomes. The model identified key factors such as weight, age, and grip strength as significant contributors to osteoporosis risk.
A yearlong randomized controlled trial found that daily prune consumption slowed bone loss connected to osteoporosis. Participants who ate at least four to six prunes every day maintained bone density and bone strength.
The International Osteoporosis Foundation (IOF) has released a position paper recommending rules for partnerships with member organizations and scientists operating in conflict zones. A survey of IOF member societies found strong consensus towards maintaining a neutral stance, supporting scientific collaboration and research.
Researchers have identified a novel target downstream of parathyroid hormone signaling that suppresses bone formation. Gprc5a negatively regulates osteoblast proliferation and differentiation by partially suppressing BMP signaling, potentially increasing teriparatide effectiveness in non-responding patients.
The IOF position paper emphasizes the need for population-specific vitamin D approaches, considering factors like diet, skin pigmentation, and supplement use. The authors also highlight the importance of standardized measures of 25(OH)D in future studies.
Research reveals that clonal hematopoiesis of indeterminate potential (CHIP) drives inflammatory bone loss diseases like periodontitis and arthritis. Rapamycin shows promise as a potential treatment for CHIP-driven inflammation.
Research presented at ENDO 2024 found that older women with low bone density are more likely to experience their first hip fracture in their 60s. A study analyzing NHANES data revealed a significant increase in osteoporosis, but surprisingly, a decrease in fragility hip fractures between 60-70 years.
Researchers discover novel suppressive role of Ctdnep1 in osteoclast differentiation and bone resorption, suggesting potential therapeutic targets for treating excessive bone loss. The study reveals that Ctdnep1 functions as a brake on osteoclast cell differentiation.
The International Osteoporosis Foundation (IOF) and ESCEO presented awards to 20 young investigators from 16 countries for their outstanding research abstracts. The awards recognize the researchers' contributions to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases.
Professor Leith Zakraoui was awarded the 2024 IOF CNS Medal for his dedicated work in advancing musculoskeletal health at both national and international levels. He has been a key figure in strengthening IOF activities in Africa and promoting education and awareness within the region.